Medienmitteilung

EANS-Adhoc: +++ Reminder +++ LifeWatch AG to report on positive Q2 2010 results on Thursday, July 29, 2010

  ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide
  distribution. The issuer is solely responsible for the content of this
  announcement.

6-month report/LifeWatch AG

19.07.2010

- 07:00 a.m. CEST: Press release/Letter to Shareholders;
- 10:00 a.m. CEST: Analyst/Media Conference; Conference Call/Webcast;

Neuhausen am Rheinfall / Switzerland - LifeWatch AG (SIX Swiss 
Exchange: LIFE) will report on its positive second quarter 2010 
results on Thursday, July 29, 2010, by issuing a Press Release and 
Letter to Shareholders at 07:00 a.m. CEST and hosting an 
English-speaking Analyst and Media Conference at 10:00 a.m. CEST at 
Zunfthaus zur Saffran, Limmatquai 54, 8001 Zürich/Switzerland. Please
register for the live Zürich conference by email to 
lifewatch@sensus.ch. The conference is also accessible as a 
conference call/webcast at:

+ 41 (0)91 610 56 00 (Europe);
+ 44 (0)207 107 06 11 (UK);
+ 1(1)866 291 41 66 (USA - Toll-free);

http://www.irlifewatch.com

About LifeWatch AG:

LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed on 
SIX Swiss Exchange (LIFE), Switzerland, is the leading healthcare 
technology and solution company, specializing in advanced telehealth 
systems and wireless remote patient monitoring services. LifeWatch 
services cater to individuals, ranging from high-risk and chronically
ill patients, to consumers of health and wellness products. LifeWatch
has subsidiaries in the United States, the Netherlands, Japan, the 
United Kingdom, Switzerland and Israel. LifeWatch AG is the parent 
company of LifeWatch Services Inc., a leading US-based cardiac 
monitoring service provider, and manufacturer of telecardiology 
products. LifeWatch is also introducing a new program for Home 
SleepTesting of Obstructive Sleep Apnea (OSA) patients under the 
brand name NiteWatch. For additional information, please visit 
www.lifewatch.com.

Sign-up for customized E-mail alerts and documentation requests is 
available at http://production.investis.com/lifewatch/alert-service/

end of announcement                               euro adhoc

Further inquiry note:

Woo Kim, Senior Vice President of Strategy and Business Development, LifeWatch
Tel +1 847 813 4299 | Fax +1 847 813 24 48 | Email wkim@lifewatch.com

Sensus Investor and Public Relations, Zürich:
Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | Email lifewatch@sensus.ch

Branche: Healthcare Providers
ISIN: CH0012815459
WKN: 1281545
Index: SPI, SPIEX
Börsen: Frankfurt / Open Market / XETRA
Berlin / free trade
SIX Swiss Exchange / Main Standard

Permalink:

https://www.presseportal.ch/de/pm/100017242/100607173